Back to Search
MARK EAGLETON, M.D., M.P.H.
M.D., M.P.H.
Anesthesiology Physician
NPI: 1306281621IndividualAccepts Medicare
Education
OTHER
Class of 2013
Research & Publications (20)
The bisphosphonate zoledronic acid decreases tumor growth in bone in mice with defective osteoclasts.
PMID 19442620·Bone·2009
7-preclinical
Late complications after endovascular thoracoabdominal aneurysm repair.
PMID 19573747·Semin Vasc Surg·2009
6-review
Endovascular management of chronic infrarenal aortic occlusion.
PMID 19281286·J Endovasc Ther·2009
8-other
Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases.
PMID 19059914·J Biol Chem·2009
7-preclinical
Endovascular treatment of stenotic and occluded visceral arteries for chronic mesenteric ischemia.
PMID 18295100·J Vasc Surg·2008
8-other
APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.
PMID 18260128·J Cell Biochem·2008
7-preclinical
Angiography underestimates peripheral atherosclerosis: lumenography revisited.
PMID 18254670·J Endovasc Ther·2008
8-other
Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone.
PMID 17715292·Proc Natl Acad Sci U S A·2007
7-preclinical
Molecular diagnoses and treatments--past, present, or future?
PMID 17580251·Semin Vasc Surg·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1 Boston Medical Ctr Pl
Boston, MA 02118 - Phone
- (617) 638-6975
Quick Facts
- NPI
- 1306281621
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile